Distribution of HLA-DRB1 and HLA-DQB1 alleles in Lak population of Iran

被引:11
作者
Varzi, Ali Mohammad [1 ]
Shahsavar, Farhad [1 ]
Tarrahi, Mohammad Javad [2 ]
机构
[1] Lorestan Univ Med Sci, Sch Med, Dept Immunol, Khorramabad, Iran
[2] Lorestan Univ Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Khorramabad, Iran
关键词
HLA class II; Lak population; Iran; PCR-SSP; HLA; FREQUENCIES; DISEASE; GENE;
D O I
10.1016/j.humimm.2016.05.011
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human leukocyte antigen (HLA) genes are the most polymorphic loci in the human genome and encode the highly polymorphic molecules critically involved in immune responses. Anthropological studies based on highly polymorphic HLA genes provide useful information for bone marrow donor registry, forensic medicine, disease association studies, as well as designing peptide vaccines against tumors, and infectious or autoimmune diseases. The aim of this study was to determine the HLA-DRB1 and HLA-DQB1 allele frequencies in 100 unrelated Lak individuals from Lorestan province of Iran. Finally, we compared the results with those previously described in four other Iranian populations. Commercial HLA-Type kits were used for determination of the HLA-DRB1 and HLA-DQB1 allele frequencies. Differences between populations in the distribution of HLA-DRB1 and HLA-DQB1 alleles were estimated by chi(2) test with Yate's correction and Fisher's exact test. The most frequent HLA-DRB1 alleles were *1103 = 4 (23%), *1502 (9.5%), *0701 (9%), *0301 (8.5%), *1101 (7.5%) and *1501 (6%) while HLA-DQB1*0301 (40%), *0201 (15%), *0502 (10.5%), *0303 (10%), *0602 = 3 (9.5%), and *0501 (7.5%) were the most frequent alleles in Lak population. HLA-DRB1*0409, *0804, *1102, *1112, *1405, and HLA-DQB1*0503, *0604 were the least observed frequencies in Lak population. Our results based on HLA-DRB1 and HLA-DQB1 allele frequencies showed that the Lak population possesses the previously reported general features of the Lur and Kurd populations but still with unique, decreased or increased frequencies of several alleles. In other words, the Lak population is close to Lurs Khorramabadi and Kurd but far from Lurs Kohkiloyeh/Boyerahmad and Bakhtiari. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:580 / 583
页数:4
相关论文
共 15 条
[1]   The origin of Cretan populations as determined by characterization of HLA alleles [J].
Arnaiz-Villena, A ;
Iliakis, P ;
González-Hevilla, M ;
Longás, J ;
Gómez-Casado, E ;
Sfyridaki, K ;
Trapaga, J ;
Silvera-Redondo, C ;
Matsouka, C ;
Martínez-Laso, J .
TISSUE ANTIGENS, 1999, 53 (03) :213-226
[2]   Population genetic relationships between Mediterranean populations determined by HLA allele distribution and a historic perspective [J].
Arnaiz-Villena, A ;
Gomez-Casdo, E ;
Martinez-Laso, J .
TISSUE ANTIGENS, 2002, 60 (02) :111-121
[3]   HLA class II similarities in Iranian Kurds and Azeris [J].
Farjadian, S. ;
Ghaderi, A. .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2007, 34 (06) :457-463
[4]   HLA class II gene polymorphism in Parsees and Zoroastrians of Iran [J].
Farjadian, S. ;
Moqadam, F. A. ;
Ghaderi, A. .
INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2006, 33 (03) :185-191
[5]   Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan [J].
Farjadian, S ;
Naruse, T ;
Kawata, H ;
Ghaderi, A ;
Bahram, S ;
Inoko, H .
TISSUE ANTIGENS, 2004, 64 (05) :581-587
[6]  
Farjadian Shirin, 2007, Iran J Immunol, V4, P85
[7]  
Farjadian Shirin, 2006, Iran J Immunol, V3, P106, DOI IJIv3i3A2
[8]   The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism [J].
Farjadian, Shirin ;
Ota, Massao ;
Inoko, Hidetoshi ;
Ghaderi, Abbas .
MOLECULAR BIOLOGY REPORTS, 2009, 36 (07) :1943-1950
[9]   Peptide-based therapeutic vaccines for allergic and autoimmune diseases [J].
Larché, M ;
Wraith, DC .
NATURE MEDICINE, 2005, 11 (04) :S69-S76
[10]   The genetics of HLA-associated disease [J].
Larsen, CE ;
Alper, CA .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (05) :660-667